Dr Lal PathLabs to buy 70% stake in a new firm to strengthen presence in MP

Dr Lal PathLabs' board has approved the signing a binding term sheet for the acquisition

Dr Lal PathLabs
Press Trust of India New Delhi
2 min read Last Updated : Jun 14 2019 | 2:11 PM IST

Diagnostic chain Dr Lal PathLabs Friday said its board has approved the acquisition of 70 per cent stake in a new company to be incorporated by Vinita Kothari and Sushila Dalal for a cash consideration not exceeding Rs 50 crore.

The company's wholly-owned subsidiary, Pathlabs Unifiers Pvt Ltd has decided to acquire 70 per cent of businesses of Central Lab, Indore and M/s 'Vinita Kothari', a proprietorship concern of Kothari, through a new company to be incorporated for strengthening its business presence in Madhya Pradesh, Dr Lal PathLabs said in a filing to BSE.

Dr Lal PathLabs' board has approved the signing a binding term sheet for the acquisition.

Central Lab, Indore, is engaged in pathology business, and is a partnership concern having Kothari and Dalal as its partners, it added.

The indicative time period for completion of the acquisition is within three months, Dr Lal PathLabs said.

The new company will be engaged in healthcare/diagnostic services in Madhya Pradesh and adjoining areas and shall house the business of Central Lab, Indore, and proprietorship concern M/s Vinita Kothari, it added.

Shares of Dr Lal PathLabs were trading at Rs 1,080 per scrip on BSE, down 0.47 per cent from their previous close.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 14 2019 | 1:55 PM IST

Next Story